Skip to main content

Identification of Kosakonia cowanii as a rare cause of acute cholecystitis: case report and review of the literature

Abstract

Background

Kosakonia cowanii, formerly known as Enterobacter cowanii, is a Gram-negative bacillus belonging to the order Enterobacterales. The species is usually recognized as a plant pathogen and has only anecdotally been encountered as a human pathogen. Here we describe the rare case of a K. cowanii infection presenting as an acute cholecystitis and provide a review of available literature. Evident difficulties in species identification by biochemical profiling suggests that potentially, K. cowanii might represent an underestimated human pathogen.

Case presentation

A 61-year old immunocompromised man presented to the hospital with fever and pain in the upper right abdomen. Sonography revealed an inflamed gall bladder and several gall stones. A cholecystectomy proved diagnosis of an acute cholecystitis with a partial necrosis of the gall bladder. Surgical specimen grew pure cultures of Gram-negative rods unambiguously identified as K. cowanii by MALDI-TOF, 16S-rRNA analysis and whole genome sequencing.

Conclusions

Reporting cases of Kosakonia species can shed light on the prevalence and clinical importance of this rare cause of human infection. Our case is the first to describe an infection without prior traumatic inoculation of the pathogen from its usual habitat, a plant, to the patient. This raises the question of the route of infections as well as the pathogen’s ability to colonize the human gut.

Peer Review reports

Background

Formerly, isolates of the species, now referred to as Kosakonia cowanii, had been placed within the species of Enterobacter agglomerans/Pantoea agglomerans. In the year 2000, the isolates were reclassified into the newly designated species of Enterobacter cowanii [1]. Brady et al. finally proposed the reclassification of the isolates under the name of Kosakonia cowanii based on multi-locus sequence analysis (Brady et al., 2013). K. cowanii is a well-recognized plant pathogen, causing a variety of infections resulting in e.g. wilt and dieback [2]. Although the primary description of K. cowanii as a distinct species also was based on isolates obtained from human specimens, the pathogenic potential in humans remains elusive. Only recently, K. cowanii has been described as a causative agent of rhabdomyolysis and bacteremia related to a rose thorn prick, indicating that infections from exogenous sources can occur [3]. In this report, K. cowanii was identified in two independent intraoperative samples obtained from an immunocompromised patient undergoing cholecystectomy for acute cholecystitis.

Case presentation

A 61-year-old man presented to the emergency department with recurrent fever of up to 38.9 °C since 4 days, nausea and pain in the upper right abdomen. He had a history of type 2 diabetes mellitus, adequately controlled with Metformin, hypertension and mild osteoporosis. Furthermore, he suffered from psoriatic arthritis, treated with Golimumab 50 mg once per month, Methotrexate 15 mg once per week and Prednisolone 7.5 mg daily.

Physical examination revealed a tender right upper quadrant and positive Murphy’s sign, while vital signs were normal. Sonography of the abdomen found several gallstones, sludge and thickening of the gallbladder wall of 7 mm. Leucocyte count was 11.9 × 109 /L and C reactive protein 144 mg/dl. Alkaline phosphatase was elevated at 241 U/l, gamma-glutamyl-transferase at 285 U/l and bilirubin at 2.1 mg/dl. According to local guidelines for the treatment of acute cholecystitis, antimicrobial therapy was initiated with intravenous cefuroxime and metronidazole, and a cholecystectomy was performed. Intraoperatively, the diagnosis of acute cholecystitis was confirmed. Partial necrosis of the gallbladder wall and purulent fluid in the right upper abdomen were evident. Cholecystectomy and extensive irrigation of the abdomen were performed laparoscopically without complications. Histology of the removed gallbladder revealed an ulcerophlegmonous cholecystitis with necrotic parts.

The patient became afebrile one day after surgery. The post-operative course was uncomplicated and the patient was discharged after 3 days. Antimicrobial therapy was changed to an oral application route and continued for additional seven days.

Microbiology

Two independent samples were collected during surgery, one swab from the inside of the gallbladder and one bile sample. Specimens were sent for routine microbiology diagnostics and streaked onto Columbia blood agar and MacConkey agar for aerobic and Schaedler agar for anaerobic incubation, respectively (all media Oxoid, Basingstoke, UK). After 24 h of aerobic and anaerobic incubation at 37 °C, both samples grew pure cultures of a Gram-negative bacillus, identified by matrix-assisted laser desorption ionization/time off light mass spectrometry fingerprinting (MALDI-TOF; Bruker, Bremen, Germany) as K. cowanii.

Species identification was confirmed by partial sequencing of the 16S ribosomal RNA (rRNA) gene, which showed 100% identity of non-ambiguous bases to the 16S rRNA of K. cowanii type strain 888–76 (GenBank accession number CP019445.1) [4]. Notably, biochemical species-level identification, performed with VITEK2 GN ID card (Biomerieux, Marcy-l’Etoile, France), incorrectly identified the strain as Pantoea spp. with a certainty of 98%.

Minimal inhibitory concentrations (MICs) were determined by gradient diffusion (Etest, Biomerieux, Marcy-l’Etoile, France; Liofilchem, Roseto degli Abruzzi, Italy), and verified by broth microdilution (Micronaut-S MDR MRGN-Screening 2 and Micronaut-S β-Lactamases, Merlin Diagnostika, Bornheim, Germany) (Table 1).

Table 1 Antimicrobial susceptibility profile of K. cowanii from a cholecystitis

Whole genome sequencing of the isolate was performed using the Illumina NextSeq platform. Reads were assembled with spades [5] and annotated with prokka [6]. The draft genome comprises 50 contigs larger than 200 base pairs with a total length of 4.9 million base pairs and a G + C-content of 56.2%. Bioinformatic analysis showed 98.4% average nucleotide identity to K. cowanii 888–76 [7], and a genome to genome distance between the two strains corresponding to a DNA-DNA hybridization relative binding ratio of 86.7% [8], thus confirming MALDI-TOF- and 16S-based species-level identification. The virulence gene profile determined with abricate (https://github.com/tseemann/abricate) and the virulence factor database [9] matched the profile of the K. cowanii type strain 887–76, which also originates from a clinical sample. In agreement with phenotypic testing (Table 1) resistance gene profiling identified a class A beta-lactamase showing 98.6% amino acid identity to the beta-lactamase of K. cowanii 888–76 (Genebank accession number APZ06536.1) but no class C beta-lactamase as typically encountered in other Enterobacter-like species. Sequencing reads have been deposited in NCBI’s small reads archive (SRR8572161). The strain was deposited at the German Collection of Microorganisms and Cell Cultures GmbH (DSMZ) (reference number DSM 108916).

Discussion and conclusions

Acute cholecystitis, which is a sudden inflammation of the gallbladder, is a common diagnosis worldwide. This disease is in more than 90% of the cases a complication of a cholecystolithiasis, complicated by an infection with predominantly Gram-negative bacteria of the order of Enterobacterales [10]. In Germany more than 63.000 cases of cholecystitis were reported in 2010 [11]. Cholecystitis is regarded as a typical endogenous infection caused by pathogens derived from the patient’s microbiota.

Here we describe the first case of cholecystitis caused by K. cowanii in an immunocompromised man. Conventionally, K. cowanii is regarded as a plant pathogen and probably only rarely causes human infections. In fact, to our knowledge only one case report so far unambiguously identified K. cowanii as a causative agent in the context of a human infection. In that patient, rhabdomyolysis and bacteremia occurred after a rose thorn prick, i.e. most likely resulted from an exogenous source potentially contaminated with K. cowanii [3]. In contrast, in our case K. cowanii caused an endogenous infection. This could have potentially resulted from ingestion of food containing K. cowanii, resulting in a transient colonization of the patient’s gut. Studies in the past have shown, that K. cowanii is a food contaminant, shown by its presence in powdered infant formula milk and on edible flowers or basil leaves [12, 13]. Further studies are needed to clarify if K. cowanii also might be able to permanently colonize the human intestine.

As so far described, patients receiving a powerful immunomodulatory medication of Golimumab and Methotrexate develop more infections than a placebo controlled group. Higher rates of infections also occurred with higher doses of Golimumab. These infections usually consist of respiratory infections up to pneumonia or urinary tract, but cases of acute cholecystitis also have been described [14, 15]. One can therefore argue that the administered medication might have facilitated the development of the infection with this rather uncommon pathogen.

It needs to be stressed that the species most probably will be misidentified if conventional biochemical differentiation systems are being employed, potentially leading to an underestimation of K. cowanii’s true importance as a human pathogen. Intriguingly, a retrospective study identified 53 pediatric cases of infection with Pantoea agglomerans, of which 7 had a penetrating trauma with a plant thorn, stick or glass shard [16]. A more thorough analysis of infections in which Pantoea agglomerans is tentatively identified as the causative agent might in fact reveal K. cowanii as the real pathogen. As already observed with other pathogens, the broad implementation of MALDI-TOF whole cell mass fingerprinting technology as the first line technique for routine microbiological differentiation might also shed light on the prevalence of K. cowanii and other plant pathogens in human infections.

Availability of data and materials

The isolate was submitted to the German Collection of Microorganisms and Cell Cultures (DSMZ) as DSM 108916.

The isolate’s 16S sequence was deposited to NCBI GenBank under accession number MK517531.

Next generation sequencing data was deposited to NCBI’s sequence read archive (SRA) under BioProject number PRJNA522304.

Abbreviations

MALDI-TOF:

Matrix-assisted laser desorption/ionization - time of flight

DSMZ:

German Collection of Microorganisms and Cell Cultures GmbH

MIC:

minimal inhibitory concentration

rRNA:

ribosomal ribonucleic acid

DNA:

Deoxyribonucleic acid

EUCAST:

European Committee on Antimicrobial Susceptibility Testing

References

  1. 1.

    Inoue K, Sugiyama K, Kosako Y, Sakazaki R, Yamai S. Enterobacter cowaniisp. Nov., a new species of the family Enterobacteriaceae. Curr Microbiol. 2000;41(6):417–20.

    CAS  Article  Google Scholar 

  2. 2.

    Brady CL, Venter SN, Cleenwerck I, Engelbeen K, de Vos P, Wingfield MJ, Telechea N, Coutinho TA. Isolation of Enterobacter cowanii from Eucalyptus showing symptoms of bacterial blight and dieback in Uruguay. Lett Appl Microbiol. 2009;49(4):461–5.

    CAS  Article  Google Scholar 

  3. 3.

    Washio K, Yamamoto G, Ikemachi M, Fujii S, Ohnuma K, Masaki T. Rhabdomyolysis due to bacteremia from Enterobacter cowanii caused by a rose thorn prick. J Dermatol. 2018;45(11):e313–4.

    Article  Google Scholar 

  4. 4.

    Yang XJ, Wang S, Cao JM, Hou JH. Complete genome sequence of human pathogen Kosakonia cowanii type strain 888-76(T). Braz J Microbiol. 2018;49(1):16–7.

    CAS  Article  Google Scholar 

  5. 5.

    Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–77.

    CAS  Article  Google Scholar 

  6. 6.

    Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–9.

    CAS  Article  Google Scholar 

  7. 7.

    Yoon SH, Ha SM, Lim J, Kwon S, Chun J. A large-scale evaluation of algorithms to calculate average nucleotide identity. Antonie Van Leeuwenhoek. 2017;110(10):1281–6.

    CAS  Article  Google Scholar 

  8. 8.

    Meier-Kolthoff JP, Auch AF, Klenk HP, Goker M. Genome sequence-based species delimitation with confidence intervals and improved distance functions. BMC Bioinformatics. 2013;14:60.

    Article  Google Scholar 

  9. 9.

    Chen L, Yang J, Yu J, Yao Z, Sun L, Shen Y, Jin Q. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res. 2005;33(Database issue):D325–8.

    CAS  Article  Google Scholar 

  10. 10.

    Liu J, Yan Q, Luo F, Shang D, Wu D, Zhang H, Shang X, Kang X, Abdo M, Liu B, et al. Acute cholecystitis associated with infection of Enterobacteriaceae from gut microbiota. Clin Microbiol Infect. 2015;21(9):851 e851–859.

    CAS  Article  Google Scholar 

  11. 11.

    Gotzky K, Landwehr P, Jahne J. Epidemiology and clinical presentation of acute cholecystitis. Chirurg. 2013;84(3):179–84.

    CAS  Article  Google Scholar 

  12. 12.

    Wetzel K, Lee J, Lee CS, Binkley M. Comparison of microbial diversity of edible flowers and basil grown with organic versus conventional methods. Can J Microbiol. 2010;56(11):943–51.

    CAS  Article  Google Scholar 

  13. 13.

    Mardaneh J, Soltan-Dallal MM. Isolation and identification of E. cowanii from powdered infant formula in NICU and determination of antimicrobial susceptibility of isolates. Iran J Pediatr. 2014;24(3):261–6.

    PubMed  PubMed Central  Google Scholar 

  14. 14.

    Tesser J, Kafka S, DeHoratius RJ, Xu S, Hsia EC, Turkiewicz A. Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those >/= 65 years of age. Arthritis Res Ther. 2019;21(1):190.

    Article  Google Scholar 

  15. 15.

    Kay J, Fleischmann R, Keystone E, Hsia EC, Hsu B, Mack M, Goldstein N, Braun J, Kavanaugh A. Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Ann Rheum Dis. 2015;74(3):538–46.

    CAS  Article  Google Scholar 

  16. 16.

    Cruz AT, Cazacu AC, Allen CH. Pantoea agglomerans, a plant pathogen causing human disease. J Clin Microbiol. 2007;45(6):1989–92.

    Article  Google Scholar 

Download references

Acknowledgments

Not applicable.

Funding

None.

Author information

Affiliations

Authors

Contributions

BB analyzed data and wrote the manuscript. EB added clinical data and contributed to manuscript preparation. MC analyzed the whole genome sequencing data. AB analyzed data and wrote the manuscript. MA and HR designed the study and wrote the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Holger Rohde.

Ethics declarations

Ethics approval and consent to participate

The study was conducted in accordance to §12 of the Hamburg Hospital Law (HmbKHG) from 17.04.1991, therefore no ethics committee approval was needed.

Consent for publication

Patient’s written informed consent to publish potentially identifying images and clinical details was obtained.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Berinson, B., Bellon, E., Christner, M. et al. Identification of Kosakonia cowanii as a rare cause of acute cholecystitis: case report and review of the literature. BMC Infect Dis 20, 366 (2020). https://doi.org/10.1186/s12879-020-05084-6

Download citation

Keywords

  • Cholecystitis
  • Diagnostics
  • Species identification
  • Kosakonia cowanii
  • Whole genome sequencing
  • Case report